ARTL Return on Tangible Equity | ARTELO BIOSCIENCES, INC.

ARTELO BIOSCIENCES, INC. (ARTL) Return on Tangible Equity

2026-06-30: Return Tang Equity -428.36%.
2026-03-31: Return Tang Equity -290.63%.
2025-12-31: Return Tang Equity 388.98%.
2025-09-30: Return Tang Equity 467.48%.

Complete source-backed return tang equity history.

Available history: 2014-08-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-428.36%
2026-03-31	-290.63%
2025-12-31	388.98%
2025-09-30	467.48%
2025-06-30	304.88%
2025-03-31	700.43%
2024-12-31	-1201.22%
2024-09-30	-211.04%
2024-06-30	-198.44%
2024-03-31	-128.09%
2023-12-31	-95.63%
2023-09-30	-76.20%
2023-06-30	-66.32%
2023-03-31	-65.94%
2022-12-31	-58.07%
2022-09-30	-45.47%
2022-06-30	-42.69%
2022-03-31	-38.69%
2021-12-31	-36.42%
2021-11-30	-31.58%
2021-09-30	-75.18%
2021-08-31	-67.13%
2021-06-30	-62.80%
2021-05-31	-60.81%
2021-03-31	-45.33%
2021-02-28	-41.07%
2020-11-30	-52.83%
2020-08-31	-120.13%
2020-05-31	-138.70%
2020-02-29	-104.29%
2019-11-30	-58.86%
2019-08-31	-39.78%
2019-05-31	-1500.75%
2019-02-28	325.01%
2018-11-30	552.09%
2018-08-31	1736.25%
2018-05-31	1936.73%
2018-02-28	-598.53%
2017-11-30	-170.89%
2017-08-31	-43.11%
2017-05-31	108.38%
2017-02-28	163.87%
2016-11-30	371.33%
2016-08-31	215.14%
2016-05-31	316.30%
2016-02-29	620.05%
2015-11-30	-4241.43%
2015-08-31	-95.92%
2015-05-31	-88.82%
2015-02-28	-255.65%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	388.98%
2024-12-31	-1201.22%
2023-12-31	-95.63%
2022-12-31	-58.07%
2021-12-31	-34.63%
2021-08-31	-61.76%
2020-08-31	-120.13%
2019-08-31	-39.78%
2018-08-31	1736.25%
2017-08-31	-43.11%
2016-08-31	215.14%
2015-08-31	-95.92%
2014-08-31	-103.65%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
TherapeuticsMD, Inc. (TXMD)	United States	$0.024B	-117.87
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
Cocrystal Pharma, Inc. (COCP)	United States	$0.022B
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
ATOSSA THERAPEUTICS, INC. (ATOS)	United States	$0.021B	-0.52
Neuphoria Therapeutics Inc. (NEUP)	United States	$0.020B	-1.77
Marker Therapeutics, Inc. (MRKR)	United States	$0.020B	-2.86
Cellectar Biosciences, Inc. (CLRB)	United States	$0.020B	-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)	United States	$0.019B	-0.31
Rocket One Inc. (RKTO)	United States	$0.019B